Anti-HCV prevalence and risk factor-based screening for hepatitis C in pregnant women and their partners in Sweden.
Charlotta MillbournCharlotte LybeckAfrodite Psaros EinbergMargareta NordinGudrun LindhIngegerd HökebergHans FredlundBjörn FischlerHelena E FadlAnn-Sofi DubergKarin LindahlPublished in: Infectious diseases (London, England) (2020)
In this study of expecting parents in two Swedish regions, the anti-HCV prevalence was 0.7% and 0.4% were viraemic, of which about 60% were previously unknown or lost to follow-up. Awaiting more studies, including cost-benefit analysis evaluating universal screening, we recommend this improved risk factor-based screening model to identify HCV-infected individuals who need follow-up and therapy.